Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO | 1.65M | -- | 1956 |
| Mr. Jesse J. Geiger BBA, CPA | President | 945.08k | -- | 1974 |
| Mr. Kevin M. Brady | CFO & Treasurer | 690.48k | 1.64M | 1974 |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations | 1.12M | 1.47M | 1963 |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary | 914.64k | 3.2M | 1969 |
| Brandon Ebken | Chief Information Officer | -- | -- | -- |
| Ms. Lauren Morris | Associate Director of Investors Relations | -- | -- | -- |
| Mr. Todd Meyers | Vice President of Business Development & Marketing | -- | -- | -- |
| John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | -- | -- | -- |
| Mr. Reinilde Heyrman M.D. | Chief Medical Officer of Medical Department | -- | -- | 1961 |
Medpace Holdings, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 5,900
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Corporate Governance
Upcoming Events
February 10, 2025 at 9:00 PM UTC
Medpace Holdings, Inc. Earnings Date